Intra-Cellular Stock In The News

ITCI
 Stock
  

USD 52.23  0.07  0.13%   

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Intra-Cellular and other traded companies coverage. We help investors stay connected with Intra-Cellular headlines for the 29th of November to make an informed investment decision based on correlating the impacts of news items on Intra-Cellular Stock performance. Please note that trading solely based on the Intra-Cellular Ther hype is not for everyone as timely availability and quick action are needed to avoid losses. The current Net Income Common Stock is estimated to decrease to about (291.6 M).
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Intra-Cellular Ther headlines in addition to utilizing other, more conventional financial analysis modules. Please see Intra-Cellular Ther Backtesting and Intra-Cellular Ther Hype Analysis.

Intra-Cellular Ther Today Top News and Investor Outlook

Intra-Cellular Ther Past News Timeline

Intra-Cellular Ther's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Intra-Cellular Ther investors visualize upcoming and past events in order to time the market based on Intra-Cellular Ther noise-free hype analysis.
Intra-Cellular Ther stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Intra-Cellular earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Intra-Cellular Ther that are available to investors today. That information is available publicly through Intra-Cellular media outlets and privately through word of mouth or via Intra-Cellular internal channels. However, regardless of the origin, that massive amount of Intra-Cellular data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Intra-Cellular Ther news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Intra-Cellular Ther relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Intra-Cellular Ther's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Intra-Cellular Ther alpha.

Intra-Cellular Largest EPS Surprises

Earnings surprises can significantly impact Intra-Cellular Ther's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-11-03
2014-09-30-0.28-0.220.0621 
2014-05-05
2014-03-31-0.23-0.170.0626 
2021-02-25
2020-12-31-0.85-0.760.0910 
2017-11-08
2017-09-30-0.62-0.530.0914 
2014-08-12
2014-06-30-0.24-0.150.0937 
2017-05-10
2017-03-31-0.72-0.620.113 
View All Earnings Estimates

Intra-Cellular Ther Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Intra-Cellular Ther Stock. The global stock market is bearish. About 65% of major world exchanges and indexes are down. See today's market update for more information.
news
21st of November 2022
Best Value Health Care Supplies Stocks to Buy in 2022 - Best Stocks
at news.google.com 
news
26th of October 2022
NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022 -...
at news.google.com 
news
20th of October 2022
Larimar Therapeutics Announces Issuance of U.S. Patent Providing Composition of Matter Pro...
at news.google.com 
Yahoo News
17th of October 2022
FDA Pushes Extends Review For Biogens Amyotrophic Lateral Sclerosis Drug - Yahoo Finance
at finance.yahoo.com 
Macroaxis News
5th of October 2022
Acquisition by Van Nostrand Robert L of 110 shares of Intra-Cellular Ther subject to Rule ...
at MacroaxisInsider 
Macroaxis News
23rd of September 2022
Exercise or conversion by Lawrence Hineline of 65164 shares of Intra-Cellular Ther subject...
at MacroaxisInsider 
news
20th of September 2022
Intra-Cellular Therapies Stock What Lies Ahead - Seeking Alpha
at news.google.com 

Intra-Cellular Ther Investors Sentiment

The influence of Intra-Cellular Ther's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Intra-Cellular. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Intra-Cellular Ther's public news can be used to forecast risks associated with investment in Intra-Cellular. The trend in average sentiment can be used to explain how an investor holding Intra-Cellular can time the market purely based on public headlines and social activities around Intra-Cellular Ther. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Intra-Cellular Ther's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intra-Cellular Ther's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Intra-Cellular Ther's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Intra-Cellular Ther.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intra-Cellular Ther in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intra-Cellular Ther's short interest history, or implied volatility extrapolated from Intra-Cellular Ther options trading.
Please see Intra-Cellular Ther Backtesting and Intra-Cellular Ther Hype Analysis. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.9 B
Quarterly Revenue Growth YOY
2.24
Return On Assets
(0.28) 
Return On Equity
(0.51) 
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.